As part of 2025 pre-budget consultations by the Department of Finance Canada, PsyCan has made a formal submission urging the Government of Canada to realize significant legal and administrative cost savings and ease regulatory burden by creating a section 56 class exemption under the Controlled Drugs and Substances Act allowing any qualified mental health professional with prescribing powers to prescribe, and any controlled substances licensed pharmacist to dispense, MDMA or psilocybin for qualifying mental health conditions.
Click here to access.